supp.fit

Lactoferrin: study protocols

68 study groups say how much Lactoferrin participants took a day. These are the doses the studies gave. They are not a recommendation.

Lactoferrin: what the research found →

Dose per serving from products

124 products in our catalogue print how much Lactoferrin a serving holds.

Most common: 50 mg to 100 mg, 23% of 124 products.

Dose per servingProducts
5 mg or less
2
5 mg to 10 mg
10
10 mg to 25 mg
11
25 mg to 50 mg
22
50 mg to 100 mg
28
100 mg to 250 mg
18
250 mg to 500 mg
19
500 mg to 1 g
9
over 1 g
5

Dose per serving from research

62 study groups in 43 studies say how much Lactoferrin participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 50 mg to 100 mg and 100 mg to 250 mg, 26% of 62 study groups each.

Daily doseStudy groups
50 mg or less
3
50 mg to 100 mg
16
100 mg to 250 mg
16
250 mg to 500 mg
7
500 mg to 1 g
8
1 g to 2.5 g
3
2.5 g to 5 g
6
over 5 g
3

Commonly used together

16 of 68 study groups took Lactoferrin with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Probiotics
3

68 study groups

Study
Efficacy of lactoferrin in preventing recurrent urinary tract infections in pregnant Egyptian women: a randomized controlled trial
2025 · Lf group · Pregnant women aged 14–24 weeks’ gestation with a history of recurrent urinary tract infection
200 mg120 days110
Evaluation of Bovine Lactoferrin for Prevention of Late-Onset Sepsis in Low-Birth-Weight Infants: A Double-Blind Randomized Controlled Trial
2025 · 150 mg bLF (arm B) · Preterm infants born at 28 to 36 + 5 weeks’ gestational age and weighing 1000 g to <2500 g at birth, without sepsis at enrollment and tolerating oral feeds
150 mg4 weeks102
Evaluation of Bovine Lactoferrin for Prevention of Late-Onset Sepsis in Low-Birth-Weight Infants: A Double-Blind Randomized Controlled Trial
2025 · 300 mg bLF (arm C) · Preterm infants born at 28 to 36 + 5 weeks’ gestational age and weighing 1000 g to <2500 g at birth, without sepsis at enrollment and tolerating oral feeds
300 mg4 weeks101
Oral lactoferrin to prevent nosocomial sepsis and necrotizing enterocolitis of premature neonates and effect on T-regulatory cells
2014 · LF group · Premature infants who were very low birth weight or born before 32 weeks
200 mg—25
The Preventive Effect of Lactoferrin-Containing Yogurt on Gastroenteritis in Nursery School Children-Intervention Study for 15 Weeks
2020 · LF group · Children aged 3–6 years attending nursery schools
100 mg15 weeks661
Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial
2014 · group LF · Very-low-birth-weight neonates (<1500 g at birth), born prematurely
100 mg45 days247
Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial
2009 · BLF alone · Very low-birth-weight infants (<1500 g) enrolled from birth; preterm neonates at risk of sepsis
100 mg45 days153
Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study
2006 · group C · Adults aged 19–84 years with Helicobacter pylori infection
400 mg7 days134
Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study
2006 · group B · Adults aged 19–84 years with Helicobacter pylori infection
400 mg7 days132
Effect of lactoferrin supplementation on the effectiveness and tolerability of a 7-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection
2007 · group B · Adults with persistent Helicobacter pylori infection after failure of a first eradication treatment
400 mg7 days34
THE EFFECT OF ENTERAL LACTOFERRIN SUPPLEMENTATION IN PREVENTION OF MORBIDITY ASSOCIATED WITH IMMATURE DIGESTIVE TRACT IN PREMATURE INFANTS: PROSPECTIVE COHORT STUDY
2022 · lactoferrin group · Premature infants with gestational age ≤32 weeks, birth weight ≤1,500 g, and age ≤72 hours
100 mg4 weeks27
Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial
2012 · group A1 · Preterm very low birth weight neonates
100 mg6 weeks—
Effects of Lactoferrin on Prevention of Acute Gastrointestinal Symptoms in Winter: A Randomized, Double-Blinded, Placebo-Controlled Trial for Staff of Kindergartens and Nursery Schools in Japan
2020 · Low LF group · Healthy adults aged 20 years or older working at kindergartens or nursery schools in Nagano Prefecture, Japan
200 mg12 weeks107
Dietary effect of lactoferrin-enriched fermented milk on skin surface lipid and clinical improvement of acne vulgaris
2010 · lactoferrin group · Adults aged 18–30 with acne vulgaris
200 mg12 weeks18
Potent anti-obesity effect of enteric-coated lactoferrin: decrease in visceral fat accumulation in Japanese men and women with abdominal obesity after 8-week administration of enteric-coated lactoferrin tablets
2010 · eLF group · Japanese men and women aged 22–60 years with abdominal obesity (BMI >25 kg/m² and visceral fat area >100 cm²)
300 mg8 weeks—
The effect of lactoferrin supplementation on death or major morbidity in very low birthweight infants (LIFT): a multicentre, double-blind, randomised controlled trial
2020 · intervention group · Very low-birthweight infants born weighing less than 1500 g and aged less than 8 days
200 mg/kg—771
Randomized Controlled Trial of Bovine Lactoferrin for Prevention of Sepsis and Neurodevelopment Impairment in Infants Weighing Less Than 2000 Grams
2020 · BLF group · Preterm infants weighing 500–2000 g at birth, enrolled in neonatal intensive care units within 72 hours after birth
200 mg/kg8 weeks209
Randomized controlled trial of lactoferrin for prevention of sepsis in peruvian neonates less than 2500 g
2015 · lactoferrin group · Neonates with birth weights of 500–2500 g, born in or referred to neonatal units within the first 72 hours of life
200 mg/kg4 weeks95
Randomized Controlled Trial of Talactoferrin Oral Solution in Preterm Infants
2016 · TLf · Preterm infants with birth weights of 750–1500 g
300 mg/kg4 weeks60
Preventing Sepsis in Preterm Infants with Bovine Lactoferrin: A Randomized Trial Exploring Immune and Antioxidant Effects
2025 · bLf · Preterm infants with very low birth weight (≤1500 g) and/or gestational age ≤32 weeks, randomized before 72 hours of age
150 mg/kg4 weeks50
Inhibition of intestinal polyp growth by oral ingestion of bovine lactoferrin and immune cells in the large intestine
2014 · 1.5 g bLF group · Adults with adenomatous colorectal polyps; age range and sex not reported
1.5 g1 year37
Inhibition of intestinal polyp growth by oral ingestion of bovine lactoferrin and immune cells in the large intestine
2014 · 3.0 g bLF group · Adults with adenomatous colorectal polyps; age range and sex not reported
3 g1 year32
Impact of lactoferrin supplementation on growth and prevalence of Giardia colonization in children
2008 · lactoferrin · Previously weaned children aged 12–36 months in Lima, Peru
1 g270 days26
Phase IB trial of oral talactoferrin in the treatment of patients with metastatic solid tumors
2010 · 4.5 g/day talactoferrin · Adults with metastatic solid tumors who had progressed on, or were ineligible for, standard chemotherapy
4.5 g——
Phase IB trial of oral talactoferrin in the treatment of patients with metastatic solid tumors
2010 · 9 g/day talactoferrin · Adults with metastatic solid tumors who had progressed on, or were ineligible for, standard chemotherapy
9 g——
Randomized, double-blind, placebo-controlled phase II study of single-agent oral talactoferrin in patients with locally advanced or metastatic non-small-cell lung cancer that progressed after chemotherapy
2011 · oral talactoferrin · Adults with stage IIIB to IV non-small-cell lung cancer whose disease progressed after one or two prior lines of systemic anticancer therapy
3 g42 weeks—
A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis
2013 · talactoferrin group · adults with severe sepsis
4.5 g4 weeks—
Effects of Lactoferrin on Prevention of Acute Gastrointestinal Symptoms in Winter: A Randomized, Double-Blinded, Placebo-Controlled Trial for Staff of Kindergartens and Nursery Schools in Japan
2020 · High LF group · Healthy adults aged 20 years or older working at kindergartens or nursery schools in Nagano Prefecture, Japan
600 mg12 weeks112
Oral administration of bovine lactoferrin for treatment of tinea pedis. A placebo-controlled, double-blind study
2000 · 600 mg lactoferrin group · Adults with mild or moderate tinea pedis
600 mg8 weeks—
The Lacuna Trial: a double-blind randomized controlled pilot trial of lactoferrin supplementation in the very preterm infant
2016 · bovine lactoferrin group · Very preterm infants born before 31 weeks gestation
100 mg——
Effects of Lactoferrin on Oral and Throat Conditions under Low Humidity Environments: A Randomized, Double-Blind, and Placebo-Controlled Crossover Trial
2023 · bLF treatment · Healthy adults aged 18–65 years
96.3 mg1 day—
Influence of bovine lactoferrin on feeding intolerance and intestinal permeability in preterm infants: a randomized controlled trial
2024 · lactoferrin group · Preterm infants aged 26–34 weeks gestational age with feeding intolerance
100 mg4 weeks—
Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial
2014 · group BLF + LGG · Very-low-birth-weight neonates (<1500 g at birth), born prematurely
100 mg45 days238
Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial
2009 · BLF plus LGG · Very low-birth-weight infants (<1500 g) enrolled from birth; preterm neonates at risk of sepsis
100 mg45 days151
Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial
2012 · group A2 · Preterm very low birth weight neonates
100 mg6 weeks—
Effects of a Bovine Lactoferrin Formulation from Cow's Milk on Menstrual Distress in Volunteers: A Randomized, Crossover Study
2016 · FeLf · Healthy women aged 20–49 with regular menstrual cycles and pain during menstruation
124 mg—35
Oral administration of bovine lactoferrin for treatment of tinea pedis. A placebo-controlled, double-blind study
2000 · 2000 mg lactoferrin group · Adults with mild or moderate tinea pedis
2 g8 weeks—
Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep Disturbance
2017 · Group A · Adults with chronic hepatitis C receiving pegylated interferon-α-2b and ribavirin
70.8 g1 year30
Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep Disturbance
2017 · Group B · Adults with chronic hepatitis C receiving pegylated interferon-α-2b and ribavirin
70.8 g1 year30
Effect of tablets containing lactoferrin and lactoperoxidase on gingival health in adults: A randomized, double-blind, placebo-controlled clinical trial
2019 · high-dose tablets · healthy adults
60 mg12 weeks—
Effect of tablets containing lactoferrin and lactoperoxidase on gingival health in adults: A randomized, double-blind, placebo-controlled clinical trial
2019 · low-dose tablets · healthy adults
20 mg12 weeks—
A Patented Dietary Supplement (Hydroxy-Methyl-Butyrate, Carnosine, Magnesium, Butyrate, Lactoferrin) Is a Promising Therapeutic Target for Age-Related Sarcopenia through the Regulation of Gut Permeability: A Randomized Controlled Trial
2024 · experimental formula · Adults aged 55–85 with sarcopenia
100 mg120 days30
Efficacy and tolerability of oral bovine lactoferrin compared to ferrous sulfate in pregnant women with iron deficiency anemia: a prospective controlled randomized study
2009 · Group A · Pregnant women with iron deficiency anemia
200 mg30 days49
A Randomized, Double-Blind, Controlled Trial to Assess the Effects of Lactoferrin at Two Doses vs. Active Control on Immunological and Safety Parameters in Healthy Adults
2025 · low-dose rhLF · Healthy men and premenopausal women aged 18–45 years
340 mg4 weeks21
Bioavailability of a Novel Form of Microencapsulated Bovine Lactoferrin and Its Effect on Inflammatory Markers and the Gut Microbiome: A Pilot Study
2018 · Product A (standard bLF), 200 mg dose · Healthy men aged 18–65 years
200 mg4 weeks6
Bioavailability of a Novel Form of Microencapsulated Bovine Lactoferrin and Its Effect on Inflammatory Markers and the Gut Microbiome: A Pilot Study
2018 · Product B (Inferrin), 200 mg dose · Healthy men aged 18–65 years
200 mg4 weeks6
Lactoferrin efficacy versus ferrous sulfate in curing iron disorders in pregnant and non-pregnant women
2010 · Arm A (pregnant women) · Pregnant women of child-bearing age suffering from iron deficiency or iron-deficiency anemia
200 mg——
Lactoferrin efficacy versus ferrous sulfate in curing iron disorders in pregnant and non-pregnant women
2010 · Arm A (non-pregnant women) · Non-pregnant women of child-bearing age suffering from iron deficiency or iron-deficiency anemia
200 mg——
Efficacy and safety of oral lactoferrin supplementation in combination with rHuEPO-beta for the treatment of anemia in advanced cancer patients undergoing chemotherapy: open-label, randomized controlled study
2010 · lactoferrin · Advanced-stage cancer patients with anemia undergoing chemotherapy
200 mg12 weeks—
Lactoferrin versus ferrous sulphate for the treatment of iron deficiency anemia during pregnancy: a randomized clinical trial
2016 · lactoferrin · Pregnant women in the second trimester with iron deficiency anemia
250 mg8 weeks—
Lactoferrin plus health education versus total dose infusion (TDI) of low-molecular weight (LMW) iron dextran for treating iron deficiency anemia (IDA) in pregnancy: a randomized controlled trial
2019 · Group A · Pregnant women in the second or third trimester with iron deficiency anemia
200 mg4 weeks—
Lactoferrin for iron-deficiency anemia in children with inflammatory bowel disease: a clinical trial
2022 · Lactoferrin group · Children aged 5–18 years with inflammatory bowel disease in remission and iron-deficiency anemia
100 mg90 days40
Bovine lactoferrin is effective to suppress Helicobacter pylori colonization in the human stomach: a randomized, double-blind, placebo-controlled study
2005 · bLF group · Healthy adults positive for H. pylori infection
400 mg12 weeks31
Oral lactoferrin as a treatment of pediatrics' anemia resulted from chronic kidney diseases: a randomized controlled trial
2025 · Group 1 (lactoferrin group) · Children and adolescents under 18 years with stage 3–5 chronic kidney disease and anemia; all participants were receiving erythropoietin.
100 mg90 days30
Bioavailability of a Novel Form of Microencapsulated Bovine Lactoferrin and Its Effect on Inflammatory Markers and the Gut Microbiome: A Pilot Study
2018 · Product A (standard bLF), 600 mg dose · Healthy men aged 18–65 years
600 mg4 weeks6
Bioavailability of a Novel Form of Microencapsulated Bovine Lactoferrin and Its Effect on Inflammatory Markers and the Gut Microbiome: A Pilot Study
2018 · Product B (Inferrin), 600 mg dose · Healthy men aged 18–65 years
600 mg4 weeks6
A Randomized, Double-Blind, Controlled Trial to Assess the Effects of Lactoferrin at Two Doses vs. Active Control on Immunological and Safety Parameters in Healthy Adults
2025 · bLF · Healthy men and premenopausal women aged 18–45 years
3.4 g4 weeks23
A Randomized, Double-Blind, Controlled Trial to Assess the Effects of Lactoferrin at Two Doses vs. Active Control on Immunological and Safety Parameters in Healthy Adults
2025 · high-dose rhLF · Healthy men and premenopausal women aged 18–45 years
3.4 g4 weeks22
Lactoferrin regulates the immune responses in post-surgical patients
2001 · LF-treated patients · Women and men, mean age 50 years, undergoing thyroid surgery
20 mg5 days18
Bovine Lactoferrin Enhances TLR7-Mediated Responses in Plasmacytoid Dendritic Cells in Elderly Women: Results From a Nutritional Intervention Study With Bovine Lactoferrin, GOS and Vitamin D
2018 · Intervention group, first 3 weeks (bLF only) · Women aged 65–85 who were generally healthy
1 g3 weeks15
Mechanisms affecting the gut of preterm infants in enteral feeding trials: a nested cohort within a randomised controlled trial of lactoferrin
2023 · Lactoferrin · Preterm infants born at less than 32 weeks’ gestation
150 mg/kg——
Lactoferrin: A Promising New Player in Treatment of Iron Deficiency Anemia in Patients on Regular Hemodialysis: A Randomized Controlled Trial
2023 · BLF group · Patients on regular hemodialysis with iron deficiency anemia
200 mg26 weeks70
A randomized, double-blind, crossover, placebo-controlled clinical trial to assess effects of the single ingestion of a tablet containing lactoferrin, lactoperoxidase, and glucose oxidase on oral malodor
2016 · Test tablet · Adults aged 20–65 with mouth-air volatile sulfur compound concentrations above the olfactory threshold; healthy adults without the listed severe diseases
20 mg1 day39
Bovine Lactoferrin Enhances TLR7-Mediated Responses in Plasmacytoid Dendritic Cells in Elderly Women: Results From a Nutritional Intervention Study With Bovine Lactoferrin, GOS and Vitamin D
2018 · Intervention group, weeks 4–6 (bLF + GOS) · Women aged 65–85 who were generally healthy
1 g3 weeks15
Bovine Lactoferrin Enhances TLR7-Mediated Responses in Plasmacytoid Dendritic Cells in Elderly Women: Results From a Nutritional Intervention Study With Bovine Lactoferrin, GOS and Vitamin D
2018 · Intervention group, weeks 7–9 (bLF + GOS + vitamin D) · Women aged 65–85 who were generally healthy
1 g3 weeks15
Effects of Long-Term Supplementation of Bovine Colostrum on Iron Homeostasis, Oxidative Stress, and Inflammation in Female Athletes: A Placebo-Controlled Clinical Trial
2022 · colostrum group · Female youth basketball players competing in first and extra-class leagues; ages not stated
60 mg24 weeks11
Inflammatory responses improve with milk ribonuclease-enriched lactoferrin supplementation in postmenopausal women
2010 · R-ELF group · Healthy postmenopausal women aged 45–60 years
250 mg26 weeks—
Supplementation With Lactoferrin and Lysozyme Ameliorates Environmental Enteric Dysfunction: A Double-Blind, Randomized, Placebo-Controlled Trial
2019 · experimental group · Children aged 12–23 months in rural Malawi
1.5 g16 weeks—